About Therapix Biosciences
Therapix Biosciences is a company based in Givatayim (Israel) founded in 2014 was acquired by FSD Pharma in October 2018. Therapix Biosciences operates in a competitive market with competitors including Heron Therapeutics, Sanity Group, Relmada, ZYUS Life Sciences and Skye Bioscience, among others.
- Headquarter Givatayim, Israel
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$8.15 M (USD), Post-IPO
Mar 05, 2021
- Investors
-
Employee Count
Not available
-
Acquired by
FSD Pharma
(Oct 22, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Therapix Biosciences
Unlock access to complete
Unlock access to complete
Funding Insights of Therapix Biosciences
Investors in Therapix Biosciences
Therapix Biosciences has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include FSD Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cannabis company engaged in cultivation, processing, and manufacturing related activities
|
Locked | Locked | Locked |
Investor details for Therapix Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Therapix Biosciences
Investment portfolio details for Therapix Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Therapix Biosciences
Detailed financials for Therapix Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Therapix Biosciences Comparisons
Peer comparison for Therapix Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Therapix Biosciences
Therapix Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Heron Therapeutics, Sanity Group, Relmada, ZYUS Life Sciences and Skye Bioscience, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Reformulated injectables for chemotherapy side effects and pain are developed.
|
|
| Locked | Locked | Locked |
Developer of cannabinoid-based pharmaceuticals and well-being products
|
|
| Locked | Locked | Locked |
Novel drug products for chronic pain treatment are developed.
|
|
| Locked | Locked | Locked |
Cannabis-derived therapeutics for multiple indications are developed.
|
|
| Locked | Locked | Locked |
Cannabinoid-based therapies for glaucoma and other diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of cannabinoid medicines for MS spasticity, cancer pain and childhood epilepsy
|
Detailed competitors of Therapix Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Therapix Biosciences
Complete news archive for Therapix Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Therapix Biosciences
Therapix Biosciences was founded in 2014 and raised its 1st funding round 5 years after it was founded.
Therapix Biosciences is headquartered in Givatayim, Israel. It is registered at Givatayim, Tel Aviv District, Israel.
Amitay Weiss is the current CEO of Therapix Biosciences.
Therapix Biosciences was founded in 2014 in Givatayim, Israel, within the biotechnology sector. Operations center on drug development for central nervous system disorders, utilizing an intellectual property portfolio of cannabinoid drugs and novel delivery systems. The pipeline features two programs: Brain Bright, a synthetic cannabinoid therapy for brain-related conditions, and a treatment for Tourette Syndrome based on the entourage effect, which has received orphan drug designation.
Therapix Biosciences's top competitors include Relmada, ZYUS Life Sciences and AlgoTx.
Therapix Biosciences has 1 investor. Key investors include FSD Pharma.